Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Secondary Sources
1.4.2. List of Primary Sources
1.4.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product Outlook
2.2.2. Regional Outlook
2.3. Competitive Insights
Chapter 3. Contraceptive Drugs and Devices Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamic
3.2.1. Market Drivers Analysis
3.2.1.1. Increasing awareness and education on reproductive health
3.2.1.2. Rising demand for family planning methods
3.2.1.3. Growing healthcare infrastructure and access
3.2.2. Market Restraints Analysis
3.2.2.1. Side effects and health concerns
3.2.3. Industry Challenges
3.2.4. Market Opportunity Analysis
3.3. Contraceptive Drugs and Devices Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal landscape
Chapter 4. Contraceptive Drugs and Devices Market: Product Estimates & Trend Analysis
4.1. Definition and Scope
4.2. Product Market Share Analysis, 2024 & 2030
4.3. Segment Dashboard
4.4. Contraceptive Drugs and Devices Market: By Product, 2018 to 2030
4.4.1. Contraceptive Drugs
4.4.1.1. Contraceptive Drugs Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.4.1.2. Contraceptive Pills
4.4.1.2.1. Contraceptive Pills Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.4.1.3. Patch
4.4.1.3.1. Patch Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.4.1.4. Injectable
4.4.1.4.1. Injectable Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.4.2. Contraceptive Devices
4.4.2.1. Contraceptive Devices Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.4.2.2. Condoms
4.4.2.2.1. Condoms Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.4.2.2.2. Male Condoms
4.4.2.2.2.1. Male Condoms Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.4.2.2.3. Female Condoms
4.4.2.2.3.1. Female Condoms Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.4.2.3. Subdermal Implants
4.4.2.3.1. Subdermal Implants Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.4.2.4. Intrauterine Devices (IUDs)
4.4.2.4.1. Intrauterine Devices (IUDs) Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.4.2.4.2. Copper IUDs
4.4.2.4.2.1. Copper IUDs Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.4.2.4.3. Hormonal IUDs
4.4.2.4.3.1. Hormonal IUDs Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.4.2.5. Vaginal Ring
4.4.2.5.1. Vaginal Ring Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.4.2.6. Diaphragm
4.4.2.6.1. Diaphragm Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
Chapter 5. Contraceptive Drugs and Devices Market: Regional Estimates & Trend Analysis by Region, Product
5.1. Definition and Scope
5.2. Regional Market Share Analysis, 2024 & 2030
5.3. Regional Market Dashboard
5.4. Contraceptive Drugs and Devices Market Share, by Region, 2024 & 2030, (USD Billion)
5.5. North America
5.5.1. North America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.5.2. U.S.
5.5.2.1. U.S. Key Country Dynamics
5.5.2.2. Regulatory Landscape and Reimbursement Scenario
5.5.2.3. Competitive Insights
5.5.2.4. U.S. Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.5.3. Canada
5.5.3.1. Canada Key Country Dynamics
5.5.3.2. Regulatory Landscape and Reimbursement Scenario
5.5.3.3. Competitive Insights
5.5.3.4. Canada Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.5.4. Mexico
5.5.4.1. Mexico Key Country Dynamics
5.5.4.2. Regulatory Landscape and Reimbursement Scenario
5.5.4.3. Competitive Insights
5.5.4.4. Mexico Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.6. Europe
5.6.1. Europe Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.6.2. UK
5.6.2.1. UK Key Country Dynamics
5.6.2.2. Regulatory Landscape and Reimbursement Scenario
5.6.2.3. Competitive Insights
5.6.2.4. U.K. Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.6.3. Germany
5.6.3.1. Germany Key Country Dynamics
5.6.3.2. Regulatory Landscape and Reimbursement Scenario
5.6.3.3. Competitive Insights
5.6.3.4. Germany Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.6.4. France
5.6.4.1. France Key Country Dynamics
5.6.4.2. Regulatory Landscape and Reimbursement Scenario
5.6.4.3. Competitive Insights
5.6.4.4. France Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.6.5. Italy
5.6.5.1. Italy Key Country Dynamics
5.6.5.2. Regulatory Landscape and Reimbursement Scenario
5.6.5.3. Competitive Insights
5.6.5.4. Italy Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.6.6. Spain
5.6.6.1. Spain Key Country Dynamics
5.6.6.2. Regulatory Landscape and Reimbursement Scenario
5.6.6.3. Competitive Insights
5.6.6.4. Spain Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.6.7. Denmark
5.6.7.1. Denmark Spain Key Country Dynamics
5.6.7.2. Regulatory Landscape and Reimbursement Scenario
5.6.7.3. Competitive Insights
5.6.7.4. Denmark Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.6.8. Sweden
5.6.8.1. Sweden Key Country Dynamics
5.6.8.2. Regulatory Landscape and Reimbursement Scenario
5.6.8.3. Competitive Insights
5.6.8.4. Sweden Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.6.9. Norway
5.6.9.1. Norway Key Country Dynamics
5.6.9.2. Regulatory Landscape and Reimbursement Scenario
5.6.9.3. Competitive Insights
5.6.9.4. Norway Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.7. Asia Pacific
5.7.1. Asia Pacific Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.7.2. China
5.7.2.1. China Key Country Dynamics
5.7.2.2. Regulatory Landscape and Reimbursement Scenario
5.7.2.3. Competitive Insights
5.7.2.4. China Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.7.3. Japan
5.7.3.1. Japan Key Country Dynamics
5.7.3.2. Regulatory Landscape and Reimbursement Scenario
5.7.3.3. Competitive Insights
5.7.3.4. Japan Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.7.4. India
5.7.4.1. India Key Country Dynamics
5.7.4.2. Regulatory Landscape and Reimbursement Scenario
5.7.4.3. Competitive Insights
5.7.4.4. India Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.7.5. South Korea
5.7.5.1. South Korea Key Country Dynamics
5.7.5.2. Regulatory Landscape and Reimbursement Scenario
5.7.5.3. Competitive Insights
5.7.5.4. South Korea Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.7.6. Australia
5.7.6.1. Australia Key Country Dynamics
5.7.6.2. Regulatory Landscape and Reimbursement Scenario
5.7.6.3. Competitive Insights
5.7.6.4. Australia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.7.7. Thailand
5.7.7.1. Thailand Key Country Dynamics
5.7.7.2. Regulatory Landscape and Reimbursement Scenario
5.7.7.3. Competitive Insights
5.7.7.4. Thailand Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.8. Latin America
5.8.1. Latin America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.8.2. Brazil
5.8.2.1. Brazil Key Country Dynamics
5.8.2.2. Regulatory Landscape and Reimbursement Scenario
5.8.2.3. Competitive Insights
5.8.2.4. Brazil Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.8.3. Argentina
5.8.3.1. Argentina Key Country Dynamics
5.8.3.2. Regulatory Landscape and Reimbursement Scenario
5.8.3.3. Competitive Insights
5.8.3.4. Argentina Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.9. Middle East and Africa (MEA)
5.9.1. Middle East and Africa Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.9.2. South Africa
5.9.2.1. South Africa Key Country Dynamics
5.9.2.2. Regulatory Landscape and Reimbursement Scenario
5.9.2.3. Competitive Insights
5.9.2.4. South Africa Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.9.3. Saudi Arabia
5.9.3.1. Saudi Arabia Key Country Dynamics
5.9.3.2. Regulatory Landscape and Reimbursement Scenario
5.9.3.3. Competitive Insights
5.9.3.4. Saudi Arabia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.9.4. UAE
5.9.4.1. UAE Key Country Dynamics
5.9.4.2. Regulatory Landscape and Reimbursement Scenario
5.9.4.3. Competitive Insights
5.9.4.4. UAE Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
5.9.5. Kuwait
5.9.5.1. Kuwait Key Country Dynamics
5.9.5.2. Regulatory Landscape and Reimbursement Scenario
5.9.5.3. Competitive Insights
5.9.5.4. Kuwait Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Chapter 6. Competitive Landscape
6.1. Recent Developments/ Strategic Initiatives & Impact Analysis by Key Market Participants
6.2. Company Categorization
6.3. Company Market Position Analysis
6.4. Strategy Mapping
6.5. Company Profiles
6.5.1. AbbVie Inc.
6.5.1.1. Participant’s Overview
6.5.1.2. Financial Performance
6.5.1.3. Product Benchmarking
6.5.1.4. Recent Developments/ Strategic Initiatives
6.5.2. Afaxys, Inc.
6.5.2.1. Participant’s Overview
6.5.2.2. Financial Performance
6.5.2.3. Product Benchmarking
6.5.2.4. Recent Developments/ Strategic Initiatives
6.5.3. Agile Therapeutics
6.5.3.1. Participant’s Overview
6.5.3.2. Financial Performance
6.5.3.3. Product Benchmarking
6.5.3.4. Recent Developments/ Strategic Initiatives
6.5.4. Bayer AG
6.5.4.1. Participant’s Overview
6.5.4.2. Financial Performance
6.5.4.3. Product Benchmarking
6.5.4.4. Recent Developments/ Strategic Initiatives
6.5.5. China Resources (Holdings) Co., Ltd.
6.5.5.1. Participant’s Overview
6.5.5.2. Financial Performance
6.5.5.3. Product Benchmarking
6.5.5.4. Recent Developments/ Strategic Initiatives
6.5.6. Church & Dwight Co., Inc.
6.5.6.1. Participant’s Overview
6.5.6.2. Financial Performance
6.5.6.3. Product Benchmarking
6.5.6.4. Recent Developments/ Strategic Initiatives
6.5.7. Cupid Limited
6.5.7.1. Participant’s Overview
6.5.7.2. Financial Performance
6.5.7.3. Product Benchmarking
6.5.7.4. Recent Developments/ Strategic Initiatives
6.5.8. Helm AG
6.5.8.1. Participant’s Overview
6.5.8.2. Financial Performance
6.5.8.3. Product Benchmarking
6.5.8.4. Recent Developments/ Strategic Initiatives
6.5.9. Johnson & Johnson Services, Inc.
6.5.9.1. Participant’s Overview
6.5.9.2. Financial Performance
6.5.9.3. Product Benchmarking
6.5.9.4. Recent Developments/ Strategic Initiatives
6.5.10. Organon Group
6.5.10.1. Participant’s Overview
6.5.10.2. Financial Performance
6.5.10.3. Product Benchmarking
6.5.10.4. Recent Developments/ Strategic Initiatives
6.5.11. Pfizer Inc.
6.5.11.1. Participant’s Overview
6.5.11.2. Financial Performance
6.5.11.3. Product Benchmarking
6.5.11.4. Recent Developments/ Strategic Initiatives
6.5.12. Veru, Inc.
6.5.12.1. Participant’s Overview
6.5.12.2. Financial Performance
6.5.12.3. Product Benchmarking
6.5.12.4. Recent Developments/ Strategic Initiatives
6.5.13. Viatris Inc.
6.5.13.1. Participant’s Overview
6.5.13.2. Financial Performance
6.5.13.3. Product Benchmarking
6.5.13.4. Recent Developments/ Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 4 U.S. contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 5 Canada contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 6 Mexico contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 7 Europe contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 8 UK contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 9 Germany contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 10 France contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 11 Italy contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 12 Spain contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 13 Denmark contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 14 Sweden contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 15 Norway contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 16 Asia Pacific contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 17 Japan contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 18 China contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 19 India contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 20 Australia contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 21 South Korea contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 22 Thailand contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 23 Latin America contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 24 Brazil contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 25 Argentina contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 26 MEA contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 27 South Africa contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 28 Saudi Arabia contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 29 UAE contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
Table 30 Kuwait contraceptive drugs and devices market estimates and forecasts by product, 2018-2030 (USD Billion)
List of Figures
Figure 1 List of Figures
Figure 2 Contraceptive Drugs and Devices Market Segmentation
Figure 3 Information Procurement
Figure 4 Data Analysis Models
Figure 5 Market Formulation and Validation
Figure 6 Data Validating & Publishing
Figure 7 Market Snapshot
Figure 8 Segment Snapshot
Figure 9 Competitive Landscape Snapshot
Figure 10 Contraceptive Drugs and Devices- Market Size and Growth Prospects (USD Billion)
Figure 11 Contraceptive Drugs and Devices Market: Market Dynamics
Figure 12 Contraceptive Drugs and Devices Market: PORTER’s Analysis
Figure 13 Contraceptive Drugs and Devices Market: PESTEL Analysis
Figure 14 Contraceptive Drugs and Devices Market Share by Product 2024 & 2030 (USD Billion)
Figure 15 Contraceptive Drugs and Devices Market, by Product: Key Takeaways
Figure 16 Contraceptive Drugs and Devices Market, by Product: Market Share, 2024 & 2030
Figure 17 Contraceptive Drugs Market Estimates & Forecasts, 2018-2030 (Revenue, USD Billion)
Figure 18 Contraceptive Pills Market Estimates & Forecasts, 2018-2030 (Revenue, USD Billion)
Figure 19 Patch Market Estimates & Forecasts, 2018-2030 (Revenue, USD Billion)
Figure 20 Injectable Market Estimates & Forecasts, 2018-2030 (Revenue, USD Billion)
Figure 21 Contraceptive Devices Market Estimates & Forecasts, 2018-2030 (Revenue, USD Billion)
Figure 22 Condoms Market Estimates & Forecasts, 2018-2030 (Revenue, USD Billion)
Figure 23 Male Condoms Market Estimates & Forecasts, 2018-2030 (Revenue, USD Billion)
Figure 24 Female Condoms Market Estimates & Forecasts, 2018-2030 (Revenue, USD Billion)
Figure 25 Subdermal Implants Market Estimates & Forecasts, 2018-2030 (Revenue, USD Billion)
Figure 26 Intrauterine Devices (IUDs) Market Estimates & Forecasts, 2018-2030 (Revenue, USD Billion)
Figure 27 Copper IUDs Market Estimates & Forecasts, 2018-2030 (Revenue, USD Billion)
Figure 28 Hormonal IUDs Market Estimates & Forecasts, 2018-2030 (Revenue, USD Billion)
Figure 29 Vaginal Ring Market Estimates & Forecasts, 2018-2030 (Revenue, USD Billion)
Figure 30 Diaphragm Market Estimates & Forecasts, 2018-2030 (Revenue, USD Billion)
Figure 31 Contraceptive Drugs and Devices Market Revenue, by Region, 2024 & 2030 (USD Billion)
Figure 32 Regional Marketplace: Key Takeaways
Figure 33 Regional Marketplace: Key Takeaways
Figure 34 North America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 35 U.S. Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 36 Canada Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 37 Mexico Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 38 Europe Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 39 UK Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030) (USD Billion)
Figure 40 Germany Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 41 France Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 42 Italy Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 43 Spain Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 44 Denmark Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 45 Sweden Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 46 Norway Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 47 Asia Pacific Contraceptive Drugs and Devices Market Estimates and Forecast, 2018-2030 (USD Billion)
Figure 48 Japan Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 49 China Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 50 India Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 51 Australia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 52 South Korea Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 53 Thailand Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 54 Latin America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 55 Brazil Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 56 Argentina Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 57 MEA Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 58 Saudi Arabia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 59 South Africa Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 60 UAE Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 61 Kuwait Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018-2030 (USD Billion)
Figure 62 Key Company Categorization
Figure 63 Company Market Positioning
Figure 64 Key Company Market Share Analysis, 2024
Figure 65 Strategic Framework
